News

You are here

Subscribe to News from The Department of Pathology and Laboratory Medicine at Weill Cornell Medical College

News Articles

Dr. Mark Rubin Elected to the Association of American Physicians

Please join us in congratulating Dr. Mark Rubin on his election to the Association of American Physicians (AAP).

AAP is a national society of physician-scientists who are elected based on their important scientific contributions that have ultimately impacted human health.  Sixty people are elected each year.

Mark A Rubin, MD
Director, Institute for Precision Medicine

Dr. David Rickman receives a 3-year DOD Impact Award

Please join us in congratulating Dr. David Rickman on receiving a 3-year $2M DOD Impact Award. He will share this award with his Co-PI, Dr. Himisha Beltran from the Department of Medicine. 

David Rickman, PhD
Assistant Professor of Pathology and Laboratory Medicine

This award will support Dr. Rickman and Beltran's work in elucidating the mechanisms by which N-Myc promotes neuroendocrine prostate cancer (NEPC) and in developing novel therapeutic agents to target N-Myc-dependent pathways critical for NEPC.

Congratulations, Drs. Rickman and Beltran!

Dr. Pengbo Zhou receives 5-year R01 from the NCI

Please join us in congratulating Dr. Pengbo Zhou on receiving a $1.3M 5-year R01 from the National Cancer Institute (NCI).

Pengbo Zhou, PhD
Professor of Pathology and Laboratory Medicine

The focus of the study is to establish the mechanistic role of the CUL4B ubiquitin ligase in the pathogenesis of colon cancer.  Dr. Zhou will also identify small molecule inhibitors of CUL4B and test their efficacy in treating colon cancer.

Congratulations, Dr. Zhou!

Dr. Nancy Du Receives $1.3M NIH/NCI Grant

Please join us in congratulating Dr. Nancy Du for receiving a 5-year $1.3M NIH/NCI grant entitled “Beyond Apoptosis, Bcl-xL in Tumor Metastasis.”

Nancy Du, PhD
Assistant Professor of Pathology and Laboratory Medicine

The focus of these studies will be to elucidate the cellular pathways that are regulated by Bcl-xL to promote cell migration and how the aberrant regulation of these pathways contributes to the formation of metastatic lesions in cancer.   

Congratulations, Dr. Du!

Dr. Mark Rubin Receives 3-Year R01 Award

Please join us in congratulating Dr. Mark Rubin on receiving a 3-year R01 award for $500k.

Along with his collaborator at Yale, Dr. Mark Gerstein, Dr. Rubin will develop approaches to identify non-coding mutations that are important for prostate cancer. 

Mark A Rubin, MD
Director, Institute for Precision Medicine

Dr. Nancy Du receives DOD Breast Cancer Breakthrough Award

Please join us in congratulating Dr. Nancy Du on receiving a DOD Breast Cancer Breakthrough Award.

Nancy Du, PhD
Assistant Professor of Pathology and Laboratory Medicine

This is a 3-year $500,000 award that will support Dr. Du’s work examining a novel function for the Bcl-xL protein in promoting cell migration and metastasis. 

Congratulations Dr. Du!

Dr. Ethel Cesarman receives $1M NIH grant

Please join us in congratulating Dr. Ethel Cesarman and her collaborators on receiving a four-year $1M grant from the NIH to develop a novel testing approach for Kaposi’s sarcoma (KS).

The study is a collaboration between Dr. Cesarman’s laboratory and laboratories at Cornell University, UCSF and the Infectious Diseases Institute in Kampala, Uganda.

Ethel Cesarman, MD, PhD
Professor of Pathology and Laboratory Medicine

Departments Partner to Host NY Perioperative Hemostasis Course

Physicians from across the country gathered in New York for a seminar on patient blood management, hosted by the Department of Anesthesiology and the Department of Pathology and Laboratory Medicine at Weill Cornell Medicine.   

The seminar, titled the New York Perioperative Hemostasis Course, included lectures, case presentations and panel discussions on a range of topics associated with the management and prevention of perioperative bleeding. It was held July 7-9 at the Cornell Club.  

Melissa Cushing, MD
Associate Professor of Clinical Pathology and Laboratory Medicine

Dr. Sandra J. Shin Appointed to Vice Chairman for Education

It is with great pleasure that I announce the appointment of Sandra J. Shin, MD, to Vice Chairman for Education, a newly created position in the Department effective July 1, 2016. Dr. Shin will continue to serve in the capacity as Director of the Pathology Residency Training Program.

Sandra J. Shin, MD
Vice Chairman for Education

In her capacity as Vice Chairman for Education, Dr. Shin will oversee the departmental fellowship programs, in addition to the residency training program. She will also expand her involvement with medical students, particularly those who are interested in pursuing a career in pathology. Dr. Shin and I will be closely engaged in further developing a strategic plan for the future direction for education in the department.

NIH Awards Grant to Four New York City Medical Centers to Advance Precision Medicine

Weill Cornell Medicine and Columbia University Medical Center, in collaboration with NewYork-Presbyterian and NYC Health + Hospitals/Harlem, have been awarded a grant from the NIH worth $4 million in the first year of funding to improve physicians' ability to prevent and treat disease based on individual differences in lifestyle, environment and genetics. The grant, which could total $46.5 million over five years, will enable researchers to enroll patients in the Cohort Program of President Barack Obama's Precision Medicine Initiative (PMI) in order to better understand the genetic and other biological drivers of disease, and how they relate to overall health.

Mark A Rubin, MD
Director, Institute for Precision Medicine

Precision medicine, an emerging approach for disease treatment and prevention, takes into account individual variability in genes, environment and lifestyle for each person. Columbia and Weill Cornell Medicine, along with several other medical centers and institutions across the country, will provide expertise and infrastructure to launch the PMI Cohort Program. This landmark research program aims to engage 1 million or more diverse U.S. volunteers in an effort to extend the success of precision medicine in some cancers to many other diseases. Importantly, the program will also focus on ways to increase a person's chances of remaining healthy throughout life.

BACK TO TOP